Group 1 - Cannara Biotech Inc. has approved the grant of incentive awards under its stock option plan and restricted share unit compensation plan [1][2] - The awards were granted in alignment with the completion of the Company's fiscal year-end on August 31, 2025, marking five consecutive years of commercial operations and year-over-year revenue growth [2] - The Company has granted 3,625,000 stock options to certain employees, each exercisable into one common share at an exercise price of $1.44 per share, vesting over three years [5] Group 2 - Cannara operates two mega facilities in Québec, covering over 1,650,000 sq. ft., with a potential annualized cultivation output of 100,000 kg [4] - The Company leverages Québec's low electricity costs to produce premium-grade cannabis products at affordable prices [4] - 145,000 restricted share units (RSUs) were granted to members of the board of directors, vesting in full on the second anniversary of the grant date [5]